We would love for you to become a part of our community. Join our Discord to connect with us and other members!

Ticker
HLS.AU

Price
1.37
Stock movement down
-0.03 (-1.79%)
Company name
Healius Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Diagnostics & Research
Market cap
994.80M
Ent value
2.88B
Price/Sales
0.33
Price/Book
0.96
Div yield
-
Div growth
-
Growth years
-
FCF payout
9.14%
Trailing P/E
-
Forward P/E
34.25
PEG
-
EPS growth
-
1 year return
-11.61%
3 year return
-35.77%
5 year return
-13.57%
10 year return
-10.77%
Last updated: 2025-01-02

DIVIDENDS

HLS.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF2.07
Price to FCF2.65
Price to EBITDA1.56
EV to EBITDA4.50

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.33
Price to Book0.96
EV to Sales0.96

FINANCIALS

Per share

Loading...
Per share data
Current share count726.13M
EPS (TTM)-1.61
FCF per share (TTM)0.52

Income statement

Loading...
Income statement data
Revenue (TTM)3.01B
Gross profit (TTM)736.00M
Operating income (TTM)348.15M
Net income (TTM)-1.17B
EPS (TTM)-1.61
EPS (1y forward)0.04

Margins

Loading...
Margins data
Gross margin (TTM)24.45%
Operating margin (TTM)11.56%
Profit margin (TTM)-38.82%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash60.10M
Net receivables187.50M
Total current assets300.10M
Goodwill1.30B
Intangible assets71.80M
Property, plant and equipment1.58B
Total assets2.98B
Accounts payable200.90M
Short/Current long term debt1.60B
Total current liabilities600.30M
Total liabilities1.94B
Shareholder's equity1.04B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)481.70M
Capital expenditures (TTM)106.30M
Free cash flow (TTM)375.40M
Dividends paid (TTM)34.30M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-112.30%
Return on Assets-39.18%
Return on Invested Capital-67.45%
Cash Return on Invested Capital21.66%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.38
Daily high1.40
Daily low1.37
Daily Volume413K
All-time high11.05
1y analyst estimate1.43
Beta0.74
EPS (TTM)-1.61
Dividend per share-
Ex-div date7 Sep 2022
Next earnings date25 Feb 2025

Downside potential

Loading...
Downside potential data
HLS.AUS&P500
Current price drop from All-time high-87.60%-3.58%
Highest price drop-90.05%-56.47%
Date of highest drop2 May 20249 Mar 2009
Avg drop from high-51.24%-11.12%
Avg time to new high85 days12 days
Max time to new high4536 days1805 days
COMPANY DETAILS
HLS.AU (Healius Ltd) company logo
Marketcap
994.80M
Marketcap category
Small-cap
Description
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Employees
4329
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found